World's Best Scientists 2026 revealed!
Vaniambadi S. Kalyanaraman

Vaniambadi S. Kalyanaraman

D-Index & Metrics

Immunology

D-Index
72
Citations
19919
World Ranking
2206
National Ranking
1068

Vaniambadi S. Kalyanaraman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Vaniambadi S. Kalyanaraman sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 207 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Vaniambadi S. Kalyanaraman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Vaniambadi S. Kalyanaraman sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 72 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Vaniambadi S. Kalyanaraman is affiliated with North Shore University Hospital in the United States. Their professional focus and research activities are connected to this institution, contributing to its academic and clinical environment.

There is no available data on recent papers authored by Vaniambadi S. Kalyanaraman. Similarly, information regarding frequent co-authors, frequent publication venues, book publications, and specific main or subfields of study has not been documented.

Details on the main topics covered in their work, as well as awards received, are also not available in the provided source data. The lack of this information limits a deeper understanding of the scientist's areas of expertise and research impact.

Despite the absence of detailed published work and research topics, Vaniambadi S. Kalyanaraman's connection to a major hospital suggests involvement in clinical research or healthcare-related academic activities. Their presence within a recognized medical institution indicates engagement with scientific or medical knowledge advancement.

Best Publications

  • Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)

    Robert C. Gallo;Prem S. Sarin;E. P. Gelmann;Marjorie Robert-Guroff

  • A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia

    VS Kalyanaraman;MG Sarngadharan;M Robert-Guroff;I Miyoshi

  • Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia.

    Bernard J. Poiesz;Francis W. Ruscetti;Marvin S. Reitz;V. S. Kalyanaraman

  • Isolation and Transmission of Human Retrovirus (Human T-Cell Leukemia Virus)

    M Popovic;PS Sarin;M Robert-Gurroff;VS Kalyanaraman

  • The human type-C retrovirus, HTLV, in blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma

    W A Blattner;V S Kalyanaraman;M Robert-Guroff;T A Lister

  • Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes.

    S Z Salahuddin;P D Markham;F Wong-Staal;G Franchini

  • The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group

    M. Popovic;M. S. Reitz;M. G. Sarngadharan;M. Robert-Guroff

  • Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients in Japan.

    V. S. Kalyanaraman;M. G. Sarngadharan;Y. Nakao;Y. Ito

  • Immunological properties of a type C retrovirus isolated from cultured human T-lymphoma cells and comparison to other mammalian retroviruses.

    V S Kalyanaraman;M G Sarngadharan;B Poiesz;F W Ruscetti

  • The acquired immunodeficiency syndrome in a cohort of homosexual men. A six-year follow-up study.

    Jaffe Hw;Darrow Ww;Echenberg Df;O'Malley Pm

  • Association of the Human Type C Retrovirus with a Subset of Adult T-Cell Cancers

    Gallo Rc;Kalyanaraman Vs;Sarngadharan Mg;Sliski A

  • Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting.

    L. Jean Patterson;Nina Malkevitch;David Venzon;Joel Pinczewski

  • Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals

    Naoki Oyaizu;Thomas W. McCloskey;Maria Coronesi;Narendra Chirmule

  • Lymphadenopathy associated virus infection of a blood donor--recipient pair with acquired immunodeficiency syndrome

    P. M. Feorino;V. S. Kalyanaraman;H. W. Haverkos;C. D. Cabradilla

  • Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion.

    Naoki Oyaizu;Thomas W. McCloskey;Soe Than;Rong Hu

  • Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus.

    V. S. Kalyanaraman;M. G. Sarngadharan;P. A. Bunn;J. D. Minna

  • Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type I strains: evidence for interspecies transmission.

    I J Koralnik;E Boeri;W C Saxinger;A L Monico

  • Human T-cell leukemia-lymphoma virus (HTLV) is in T but not B lymphocytes from a patient with cutaneous T-cell lymphoma

    R C Gallo;D Mann;S Broder;F W Ruscetti

  • Epidemiology of Human T-Cell Leukemia/Lymphoma Virus

    Blattner Wa;Blayney Dw;Robert-Guroff M;Sarngadharan Mg

  • Adjuvant-dependent Innate and Adaptive Immune Signatures of Risk of SIVmac251 Acquisition

    Monica Vaccari;Shari N Gordon;Slim Fourati;Luca Schifanella;Luca Schifanella

Frequent Co-Authors

Marjorie Robert-Guroff
Marjorie Robert-Guroff National Institutes of Health
Robert C. Gallo
Robert C. Gallo University of South Florida
David Venzon
David Venzon National Institutes of Health
Ranajit Pal
Ranajit Pal Advanced Bioscience Laboratories (United States)
David C. Montefiori
David C. Montefiori Duke University
Savita Pahwa
Savita Pahwa University of Miami
Phillip D. Markham
Phillip D. Markham Northrop Grumman (United States)
Narendra Chirmule
Narendra Chirmule Amgen (United States)
Genoveffa Franchini
Genoveffa Franchini National Institutes of Health
Harold W. Jaffe
Harold W. Jaffe Centers for Disease Control and Prevention

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology often opens doors to various healthcare and research careers. For those interested in nursing roles with a focus on mental health, exploring the best psychiatric mental health nurse practitioner programs online can be a great step. These programs offer specialized training and often boast excellent clinical placement rates, ensuring hands-on experience.

If cost is a concern, there are also options available that balance quality with affordability. Students can find some of the cheapest online pmhnp certificate programs designed to provide essential knowledge without excessive tuition fees.

Advancing your career with degrees like a Doctor of Nursing Practice (DNP) can significantly impact your earning potential. To understand potential earnings, it’s helpful to review the doctor of nursing practice salary across different states, as this can guide job location decisions.

For nurse practitioners aiming to specialize, additional certifications such as the acute care nurse practitioner certification offer pathways to work with patients requiring intensive or specialized care. Transitioning through these programs can broaden your professional scope within the healthcare field.

Best Scientists Citing Vaniambadi S. Kalyanaraman

Trending Scientists

Recently Published Articles